Prognostic evaluation of NANOG and OCT4 expression for posttransplantation hepatocellular carcinoma recurrence.

Cai, Wenjuan; Wang, Zhenglu; Wei, Chunfang; Wu, Meng; Zheng, Weiping; Zhang, Haiming; Liu, Chenghu; Liu, Lei

Cai, Wenjuan; Wang, Zhenglu; Wei, Chunfang; Wu, Meng; Zheng, Weiping; Zhang, Haiming; Liu, Chenghu; Liu, Lei.

Afiliación

Cai W; Pathology Department, Tianjin First Center Hospital, Tianjin, China.
Wang Z; Pathology Department, Tianjin First Center Hospital, Tianjin, China.
Wei C; Biobank, Tianjin First Center Hospital, Tianjin, China.
Wu M; School of Medicine, Nankai University, Tianjin, China.
Zheng W; School of Medicine, Nankai University, Tianjin, China.
Zhang H; Organ Transplant Center, Tianjin First Center Hospital, Tianjin, China.
Liu C; Key Lab for Critical Care Medicine of the Ministry of Health, Tianjin First Center Hospital, Tianjin, China.
Liu L; School of Medicine, Nankai University, Tianjin, China.

J Cell Biochem ; 120(5): 8419-8429, 2019 May.

Article en En | MEDLINE | ID: mdl-30506712

Palabras clave

NANOG; OCT4; hepatocellular carcinoma; liver transplantation; overall survival; recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Cell Biochem Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google